Dr Reddy's Laboratories today said it has launched Montelukast Sodium tablets, used for treating asthma and allergies, in the US market after getting approval from the American health regulator.
The company received approval from US Food and Drug Administration for Montelukast Sodium tablets and Montelukast Sodium chewable tablets in strengths ranging from 4 mg to 10 mg, Dr Reddy's Laboratories said in a statement.
Dr Reddy's launched tablets in the US market yesterday, it added. The Hyderabad-based firm's products are generic versions of Merck & Co's Singulair tablets and chewable tablets.
According to IMS Health data, Singulair tablets and chewable tablets brand had sales of about $3.6 billion and $1.14 billion, respectively, in the US market for the year ended March 2012.
"Dr Reddy's Montelukast Sodium tablets in 10 mg and Montelukast Sodium chewable tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90," the company said.
Shares of Dr Reddy's Laboratories today closed at Rs 1,657.40 apiece on the BSE, down 0.01% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app